AU3981097A - Controlled release microparticles with a hydrophobic material - Google Patents

Controlled release microparticles with a hydrophobic material

Info

Publication number
AU3981097A
AU3981097A AU39810/97A AU3981097A AU3981097A AU 3981097 A AU3981097 A AU 3981097A AU 39810/97 A AU39810/97 A AU 39810/97A AU 3981097 A AU3981097 A AU 3981097A AU 3981097 A AU3981097 A AU 3981097A
Authority
AU
Australia
Prior art keywords
controlled release
hydrophobic material
release microparticles
microparticles
hydrophobic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39810/97A
Inventor
R. Craig Urian
Yan Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alkermes Controlled Therapeutics Inc
Original Assignee
Alkermes Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alkermes Inc filed Critical Alkermes Inc
Publication of AU3981097A publication Critical patent/AU3981097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
AU39810/97A 1996-08-21 1997-08-14 Controlled release microparticles with a hydrophobic material Abandoned AU3981097A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70122996A 1996-08-21 1996-08-21
US08701229 1996-08-21
PCT/US1997/014320 WO1998007412A1 (en) 1996-08-21 1997-08-14 Controlled release microparticles with a hydrophobic material

Publications (1)

Publication Number Publication Date
AU3981097A true AU3981097A (en) 1998-03-06

Family

ID=24816520

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39810/97A Abandoned AU3981097A (en) 1996-08-21 1997-08-14 Controlled release microparticles with a hydrophobic material

Country Status (2)

Country Link
AU (1) AU3981097A (en)
WO (1) WO1998007412A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69705746T2 (en) 1996-12-20 2001-10-31 Alza Corp INJECTABLE DEPOT GEL PREPARATION AND PRODUCTION METHOD
ATE428371T1 (en) * 1998-07-17 2009-05-15 Pacira Pharmaceuticals Inc BIODEGRADABLE ARRANGEMENTS FOR THE CONTROLLED RELEASE OF ENCLOSED SUBSTANCES
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
KR101200728B1 (en) 2006-08-09 2012-11-13 인타르시아 세라퓨틱스 인코포레이티드 Osmotic delivery system and piston assemblies
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
ES2630805T3 (en) 2008-07-14 2017-08-24 Polypid Ltd. Sustained release drug vehicle composition
FI2341905T4 (en) 2008-09-04 2023-12-04 Amylin Pharmaceuticals Llc Sustained release formulations using non-aqueous carriers
WO2011007353A1 (en) 2009-07-14 2011-01-20 Polypid Ltd. Sustained-release drug carrier composition
SI2462246T1 (en) 2009-09-28 2018-01-31 Intarcia Therapeutics, Inc. Rapid establishment and/or termination of substantial steady-state drug delivery
US8795726B2 (en) 2010-01-19 2014-08-05 Polypid Ltd. Sustained-release nucleic acid matrix compositions
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR20240042548A (en) 2015-06-03 2024-04-02 인타르시아 세라퓨틱스 인코포레이티드 Implant placement and removal systems
MA53353A (en) 2016-05-16 2021-06-09 Intarcia Therapeutics Inc GLUCAGON RECEPTOR SELECTIVE POLYPEPTIDES AND METHODS FOR THEIR USE
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
EP3565580B1 (en) 2017-01-03 2024-03-06 i2o Therapeutics, Inc. Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61174940A (en) * 1985-01-29 1986-08-06 Oogawara Kakoki Kk Single core microcapsule coated with wax and its preparation
DE4223169C1 (en) * 1992-07-10 1993-11-25 Ferring Arzneimittel Gmbh Process for the microencapsulation of water-soluble active substances
US5718922A (en) * 1995-05-31 1998-02-17 Schepens Eye Research Institute, Inc. Intravitreal microsphere drug delivery and method of preparation

Also Published As

Publication number Publication date
WO1998007412A1 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
AU7351198A (en) Encapsulated material with controlled release
AU3882197A (en) Loop fastening material
AUPM897594A0 (en) Controlled release container
AU689875B2 (en) Reinforced friction material
AU3981097A (en) Controlled release microparticles with a hydrophobic material
AU2385597A (en) Antibodies against the advanced glycosylation end-product receptor and uses thereof
AU3406497A (en) Controlled release tablet
AU2897297A (en) Microparticles
AU7952398A (en) Control device
AU4309797A (en) Polymeric material
AU6660198A (en) Container having fluid-weight control device
AU1790597A (en) Solid, adhesive material which peels off smoothly
AU6927798A (en) Haemodynamic control device
AU7874298A (en) Lining material
AU5467898A (en) Fibres coated with hydrophobic material
AU3940697A (en) Pesticides
AU7432998A (en) Arid-polymer construction material
AU7952298A (en) Control device
AU2499997A (en) Reinforcement material
AU8136798A (en) Control device
AU7423596A (en) A control device
AU736432C (en) Braking device with region controlled weakness
AU3352297A (en) Controlled release tablets
AU6400496A (en) Retroreflective material
AU1751697A (en) Small particle size latexes